COMMUNIQUÉS West-GlobeNewswire

GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC
10/01/2019
GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC Lille (France); Cambridge (Massachusetts, United States) - January 10, 2019 - GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the [...]
GENFIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC
10/01/2019
GENFIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC Lille (France) ; Cambridge (Massachusetts, Etats-Unis) - 10 janvier 2019 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2018
10/01/2019
Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 31 décembre 2018
10/01/2019
Nombre total de droits de vote et d'actions composant le capital social au 31 décembre 2018 (Conformément à l'article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l'AMF) [...]
Holding(s) in Company
10/01/2019
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
ASCO and Tempus Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization (TAPUR™) Study
10/01/2019
ALEXANDRIA, Va. and CHICAGO, Jan. 10, 2019 (GLOBE NEWSWIRE) -- The American Society of Clinical Oncology, Inc. (ASCO) and Tempus announced today an agreement to support research sites participating in ASCO’s Targeted [...]
EMA Grants Orphan Drug Designation to Rafael Pharmaceuticals’ devimistat (CPI-613®) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
10/01/2019
Newark, NJ, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that the European Medicines Agency (EMA) has granted [...]
Janis Romanovskis reelected to the Board of JSC “Grindeks”
10/01/2019
Supervisory Council of JSC "Grindeks" reelected Janis Romanovskis to position of Board Member. Therefore the composition of the Board JSC "Grindeks” is maintained as before. Further information: Laila Kļaviņa Head of [...]
Cerner to Release Fourth Quarter 2018 Earnings Results February 5
10/01/2019
KANSAS CITY, Mo., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its fourth quarter 2018 earnings results after the market closes Tuesday, February 5. Following the [...]
NRC Health Partners with TennCare to Improve Quality of Care and Resident Satisfaction in Medicaid Nursing Facilities Across Tennessee
10/01/2019
The implementation of new survey tools will help create consistent performance benchmarks in 2019 LINCOLN, Neb., Jan. 10, 2019 (GLOBE NEWSWIRE) -- NRC Health , the leader in supporting and advancing state quality [...]
DLT Resolution Provides Digitization & Call Center Services to Large Canadian City
10/01/2019
Las Vegas, NV, Jan. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) data management and Information Technology company, is pleased to [...]
Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas
10/01/2019
Company on track to submit Investigational New Drug application for CPI-818 in early 2019 BURLINGAME, Calif., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage [...]
Daxor Corporation Announces Acquisition of BVA-100® Blood Volume Analyzer to Aspirus Wausau Hospital in Wisconsin
10/01/2019
NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Aleafia Has Buyers Lined Up as Greenhouse Goes into Production -- CFN Media
10/01/2019
SEATTLE, Jan. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
CTD Announces Presentation at Upcoming Conference on Lysosomal Storage Diseases
10/01/2019
Annual conference offers opportunities for academic researchers and industry representatives to exchange information on novel therapeutic interventions ALACHUA, Fla., Jan. 10, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc [...]
EMA Grants Orphan Drug Designation to Rafael Pharmaceuticals’ devimistat (CPI-613®) for Treatment of Metastatic Pancreatic Cancer
10/01/2019
Newark, NJ, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that the European Medicines Agency (EMA) has granted [...]
Shital Mars CEO of Progressive Care Inc. Garners Coverage in Authority Magazine as a Hero of the Opioid Crisis
10/01/2019
MIAMI, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Authority Magazine as a [...]
HempAmericana Signs Letter of Intent to Purchase Entire Hemp Crop from Key Supplier
10/01/2019
NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company has signed a Letter of Intent (“LOI”) for the [...]
Matinas BioPharma Announces a Research Evaluation with Top Global Pharma Company Based on Its Proprietary Drug Delivery Platform
10/01/2019
- Matinas to formulate select oligonucleotides using its proprietary, lipid nano-crystal platform delivery technology - BEDMINSTER, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: [...]

Pages